Domestic corporations of multinational pharmaceutical companies are gaining a benefit due to domestic companies chllange to develop biosimilar
It was identified that domestic corporations of multinational pharmaceutical companies which hold original biomedicine are gaining a benefit due to domestic companies chllange to develop biosimilar.
Multinational pharmaceutical companies which hold original biomedicine are of cource not delighte...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
